Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $37.1 million.

  • Eton Pharmaceuticals' Cash & Current Investments rose 8321.41% to $37.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year increase of 8321.41%. This contributed to the annual value of $14.9 million for FY2024, which is 3016.64% down from last year.
  • Eton Pharmaceuticals' Cash & Current Investments amounted to $37.1 million in Q3 2025, which was up 8321.41% from $25.4 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Cash & Current Investments' 5-year high stood at $37.1 million during Q3 2025, with a 5-year trough of $13.4 million in Q3 2022.
  • Its 5-year average for Cash & Current Investments is $20.0 million, with a median of $17.7 million in 2024.
  • Per our database at Business Quant, Eton Pharmaceuticals' Cash & Current Investments skyrocketed by 20972.45% in 2021 and then crashed by 4108.94% in 2022.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Cash & Current Investments stood at $14.4 million in 2021, then grew by 13.18% to $16.3 million in 2022, then skyrocketed by 31.17% to $21.4 million in 2023, then tumbled by 30.17% to $14.9 million in 2024, then surged by 148.53% to $37.1 million in 2025.
  • Its Cash & Current Investments was $37.1 million in Q3 2025, compared to $25.4 million in Q2 2025 and $17.4 million in Q1 2025.